Jiayu Wang

In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo et al. · Frontiers in Oncology · 2022 · 119 citations · Full text

Medicine, Oncology, Pathology +17

RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with HER2-positive and HER2-low expressing advanced or metastatic breast cancer: A pooled analysis of two studies.

Jiayu Wang, Yunjiang Liu, Qingyuan Zhang et al. · Journal of Clinical Oncology · 2021 · 102 citations

Medicine, Oncology, Pharmacology +15

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Qiao Li, Xiuwen Guan, Shanshan Chen et al. · Clinical Cancer Research · 2019 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +17

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

Jiayu Wang, Binghe Xu, Peng Yuan et al. · Breast Cancer Research and Treatment · 2012 · 72 citations

Medicine, Cancer Biology, Oncology +17

Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience

Hangcheng Xu, Yiqun Han, Yun Wu et al. · Frontiers in Oncology · 2022 · 71 citations · Full text

Medicine, Oncology, Pathology +14